Table 1.
Patient demographics and distribution of pediatric blood samples used for each assay
| Total enrolled (n = 152) | Pediatric controls (n = 78) | COVID-19 (n = 43) | MIS-C (n = 31) |
|---|---|---|---|
| Age, mean years (min, max) | 10.9 (1.2, 20) | 14.2 (0.04, 22.2) | 7.4 (0.17, 21) |
| Female gender, n (%) | 39 (50) | 14 (33) | 9 (29) |
| Male gender, n (%) | 39 (50) | 29 (67) | 22 (71) |
| Race, n (%) | |||
| White | 43 (55) | 15 (34) | 13 (42) |
| Black or African American | 3 (4) | 4 (9) | 5 (16) |
| Asian | 7 (9) | 2 (5) | 2 (6) |
| Ethnicity, n (%) | |||
| Hispanic or Latino | 28 (36) | 21 (51) | 13 (42) |
| Samples used in assays, n | |||
| RNA sequencing | 12 | 19 | 17 |
| Proteomics | 23 | 19 | 13 |
| Cell-free DNA | 21 | 23 | 19 |
| Spontaneous NETosis | 14 | 0 | 7 |